Peritransplant Renal Dysfunction in Liver Transplant Candidates

Area of Science:

• Nephrology
• Hepatology
• Transplantation Medicine

Background:

• Renal function is closely linked to prognosis and Model for End-Stage Liver Disease (MELD) scores in cirrhosis patients.
• Estimating glomerular filtration rate (GFR) and identifying renal impairment causes are critical, especially around liver transplantation.
• Accurate renal assessment is vital for stratifying patients for liver-kidney transplantation versus liver transplantation alone.

Purpose of the Study:

• To highlight the importance of accurate renal function assessment in cirrhotic patients undergoing liver transplantation evaluation.
• To introduce novel biomarkers for improved diagnosis of renal dysfunction and its etiologies in this population.

Main Methods:

• Review of current literature on renal function assessment in cirrhosis.
• Discussion of novel biomarkers such as cystatin C and urinary neutrophil gelatinase-associated lipocalin (uNGAL).
• Analysis of the role of these biomarkers in differentiating renal impairment causes and severity.

Main Results:

• Novel biomarkers (cystatin C, uNGAL) offer more accurate assessment of renal dysfunction compared to traditional methods.
• These biomarkers aid in diagnosing the etiology and chronicity of renal impairment in cirrhotic patients.
• Improved renal assessment facilitates better patient stratification for transplantation.

Conclusions:

• Accurate assessment of renal dysfunction severity and chronicity is imperative for cirrhotic liver transplant candidates.
• Novel biomarkers enhance diagnostic capabilities, aiding in decisions regarding simultaneous liver-kidney transplantation.
• Precise renal evaluation optimizes patient selection and improves outcomes in liver transplantation.